Trials / Sponsors / MiNK Therapeutics
MiNK Therapeutics
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | A Study Investigating agenT-797 in Participants With Relapsed/Refractory Solid Tumors Tumor, Solid | Phase 1 | 2022-01-28 |
| Completed | agenT-797 in Participants With Relapsed/Refractory Multiple Myeloma Relapsed/Refractory Multiple Myeloma | Phase 1 | 2021-03-29 |
| Completed | A Clinical Trial to Evaluate the Safety of agenT-797 in COVID-19 Participants With ARDS Respiratory Distress Syndrome, Adult | Phase 1 | 2020-09-21 |